Tyrosine kinase inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tyrosine kinase inhibitor (unspecified), covering 2016-02-24 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [Phase 2]